查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
生物製藥塑膠市場 - 2018-2028 年全球行業規模、佔有率、趨勢、機會和預測，按聚合物類型（聚氯乙烯、聚對苯二甲酸乙二酯、聚丙烯、其他）、應用、地區和競爭情況細分
市場調查報告書
商品編碼
1309872

生物製藥塑膠市場 - 2018-2028 年全球行業規模、佔有率、趨勢、機會和預測，按聚合物類型（聚氯乙烯、聚對苯二甲酸乙二酯、聚丙烯、其他）、應用、地區和競爭情況細分

Biopharma Plastics Market- Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented By Polymer Type (Polyvinyl Chloride, Polyethylene Terephthalate, Polypropylene, Others), By Application, By Region, and Competition
出版日期: | 出版商: TechSci Research | 英文 115 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

由於醫療保健行業的需求不斷成長，預計到2028 年，生物製藥塑膠市場將大幅擴張。 2020 年，印度醫療保健行業的產值約為2800 億美元。

醫療保健領域持續的技術進步

利用奈米顆粒控製藥物釋放和靶向給藥的系統被稱為奈米給藥系統。這些都是治療微生物、心血管、炎症、自身免疫和癌症疾病的新興技術。由於奈米技術具有特定部位和靶向給藥能力，治療心血管疾病（CVDs）等慢性疾病變得更加容易。為防止這些藥物受到環境影響，生產了特殊類型的包裝套件。

例如，根據ETHealthWorld 的報導，奈米技術將塑造醫療保健的未來。

因此，醫療保健設施的增加和技術的進步將推動未來幾年的市場成長。

注射器適用性主導市場

注射器是一種重要的醫療產品，用於注射和抽取體內液體。預灌封注射器使用方便、成本低、微生物污染少、注射錯誤率低、稀釋錯誤率低，因此市場對其的需求不斷增加。預灌封注射器減少了注射步驟，提高了劑量的準確性，降低了受傷和交叉感染的風險。

此外，預灌封注射器現已成為藥物生命週期中的一個常見組成部分，早在藥物開發過程的第二階段就已被涵蓋考慮範圍。

例如，根據《藥物開發與交付》雜誌的報導，預灌封注射器和自動注射器的生產重點是滿足患者的需求，提供各種腸外用藥量，並允許不同的給藥方案。

因此，對預灌封注射器的日益關注將促進全球生物製藥塑膠市場在預測期內的成長。

聚氯乙烯（PVC）將成為主要聚合物類型。

聚氯乙烯之所以在市場上用途廣泛，是因為它能夠承受各種操作而不會斷裂或開裂。由於聚氯乙烯具有柔韌性、抗紫外線和耐化學性，並可隨時承受高溫，因此是製造注射器、 拋棄式連接件、深度過濾器和其他生物製藥塑膠產品的理想材料。除了具有出色的機械性能外，它們還具有抗氧化能力、同時具有透汽性的憎水性和防水性。因此，這種產品具有持久性、永續性和成本效益，從而增加了生物製藥塑膠在醫療保健行業防護服中的使用。

例如，根據MPN 的數據，2021 年，聚氯乙烯是 拋棄式醫療器械（如袋子、管道、口罩和其他處置裝置）中使用最多的聚合物。

此外，聚四氟乙烯和聚乙烯因其耐用性、光澤度和耐洗滌劑性等特性而被廣泛應用。

因此，上述因素可能會在預測期內促進市場成長。

最新動態

  • 2022 年11 月， Avantor 公司在愛爾蘭都柏林開設了新的分銷中心，為生物製藥市場提供支持。
  • 2022 年11 月，蘇威與法國初創企業Ostiumin 簽署合作備忘錄，以實現以玻璃纖維增強模塑的報廢 拋棄式外科手術器械的機械回收。
  • 2022 年9 月，韓華解決方案公司開始在韓國麗水使用利安德巴塞爾Lupotech T 高壓聚乙烯技術。
  • 2022 年7 月，杜邦公司在南卡羅來納州庫珀河基地開設了醫療保健解決方案製造工廠DuPont Liveo 。

可客製化

TechSci Research 可根據給定的市場數據，按照公司的具體需求提供客製化服務。報告可提供以下客製化選項：

公司資訊

  • 其他市場參與者（最多五家）的詳細分析和概況。

目錄

第1 章：產品概述

  • 市場定義
  • 市場範圍
    • 覆蓋市場
    • 研究年份
    • 主要市場細分

第2 章：研究方法

  • 研究目的
  • 基準方法
  • 主要行業合作夥伴
  • 主要協會和二手資料來源
  • 預測方法
  • 數據三角測量與驗證
  • 假設和限制

第3 章：執行摘要

  • 市場概述
  • 主要市場細分概述
  • 主要市場參與者概述
  • 主要地區/國家概述
  • 市場驅動因素、挑戰和趨勢概述

第4章：客戶之聲

第5 章: 全球生物製藥塑膠市場展望

  • 市場規模和預測
    • 按價值和數量
  • 市場佔有率與預測
    • 按聚合物類型（聚氯乙烯（PVC）、聚對苯二甲酸乙二酯（PET）、聚丙烯（PP）及其他）
    • 按應用（防護服、容器、生物反應器袋、注射器及其他）
    • 按地區（北美、歐洲、亞太地區、南美、中東和非洲）
    • 按公司（2022 年）
  • 市場地圖
    • 按聚合物類型
    • 按應用
    • 按地區

第6 章：北美生物製藥塑膠市場展望

  • 市場規模與預測
    • 按價值和數量
  • 市場佔有率與預測
    • 按聚合物類型
    • 按應用
    • 按國家
  • 定價分析
  • 北美洲：國家分析
    • 美國
    • 墨西哥
    • 加拿大

第7 章：歐洲生物製藥塑膠市場展望

  • 市場規模與預測
    • 按價值和數量
  • 市場佔有率與預測
    • 按聚合物類型
    • 按應用
    • 按國家
  • 定價分析
  • 歐洲：國家分析
    • 法國
    • 德國
    • 英國
    • 西班牙
    • 義大利

第8 章：亞太地區生物製藥塑膠市場展望

  • 市場規模和預測
    • 按價值和數量
  • 市場佔有率與預測
    • 按聚合物類型
    • 按應用
    • 按國家
  • 定價分析
  • 亞太地區：國家分析
    • 中國
    • 印度
    • 韓國
    • 日本
    • 印尼

第9章：南美洲生物製藥塑膠市場展望

  • 市場規模與預測
    • 按價值和數量
  • 市場佔有率與預測
    • 按聚合物類型
    • 按應用
    • 按國家
  • 定價分析
  • 南美洲：國家分析
    • 巴西
    • 阿根廷

第10 章：中東和非洲生物製藥塑膠市場展望

  • 市場規模與預測
    • 按價值和數量
  • 市場佔有率與預測
    • 按聚合物類型
    • 按應用
    • 按國家
  • 定價分析
  • 中東和非洲：國家分析
    • 南非生物製藥塑膠
    • 沙烏地阿拉伯生物製藥塑膠
    • 阿拉伯聯合大公國生物製藥塑膠

第11 章：市場動態

  • 驅動因素
    • 醫療保健支出增加
    • 癌症患者人數增加
    • 醫療保健技術進步
  • 挑戰
    • 原料價格波動
    • 嚴格的政府法規

第12 章：市場趨勢與發展

  • 產品上市
  • 合併與收購
  • 技術進步

第13 章：全球生物製藥塑膠市場：SWOT 分析

第14章：波特五力分析法

  • 行業競爭
  • 新進入者的潛力
  • 供應商的力量
  • 客戶的力量
  • 替代品的威脅

第15 章：競爭格局

  • 業務概述
  • 產品類型
  • 近期發展
  • 財務狀況（上市公司）
  • 主要人員
  • SWOT 分析
    • BASF SE
    • Spectrum Plastics Group
    • Celanese Corporation
    • LyondellBasell Industries Holdings BV
    • DuPont de Nemours, Inc.
    • Tekni-Plex, Inc.
    • Solvay SA
    • Avantor, Inc.
    • Bormioli Pharma SpA
    • Saudi Basic Industries Corporation

第16 章：戰略建議

簡介目錄
Product Code: 14963

Biopharma Plastics Market is anticipated to expand significantly through 2028 due to the growing demand from the healthcare sector. In 2020, India's healthcare sector was worth about USD 280 billion.

Due to their features, such as low chemical reactivity, thermal stability, and high resistivity, biopharma plastics are widely used in the production of several healthcare products, including protective clothing, containers, syringes, disposable connections, and bioreactor bags. Moreover, factors, including rising global healthcare costs and an increase in the number of cancer cases worldwide, therefore surge the demand for singe use plastic in the production of containers, syringes, and others, leading to the growth of Global Biopharma Plastics Market in the projected period.

Ongoing Technological Advancement in Healthcare

Systems for the controlled release and targeted delivery of medicinal drugs using nanoparticles are known as nano-drug delivery systems. These are brand-new yet emerging technologies for treating microbiological, cardiovascular, inflammatory, autoimmune, and cancerous disorders. Due to the site-specific and target-oriented medication delivery capabilities of nanotechnology, treating chronic illnesses like cardiovascular diseases (CVDs) is made much easier. The special type of packaging kits is manufactured in the prevention of these drugs from the environment.

For instance, according to the ETHealthWorld, Nanotechnology is poised to shape the future of healthcare, and The space where nanotechnology meets healthcare is called nanomedicine.

Therefore, an increase in healthcare facilities and advancement in technology anticipates market growth in the upcoming years.

Syringe Applicability Dominates the Market

For injecting & withdrawing liquid from the body, syringes are a prominent healthcare product. The increase in demand for prefilled syringes is due to their ease of use, low cost, minimum microbiological contamination, low injection mistakes, and low dilution errors. Pre-filled syringes reduce the number of steps for injection, offer higher dose accuracy, and lower the risk of injury and cross-contamination.

Moreover, Pre-filled syringes are now a commonplace component of the medication life cycle and are frequently taken into consideration as early as Phase II of the drug development process.

For Instance, according to Drug Development & Delivery, Prefilled syringes and autoinjectors are manufactured focusing on the needs of the patient by providing a variety of parenteral medication quantities and allowing variable dosing regimens.

Thus, the increasing focus on prefilled syringes will lead to the growth of the Global Biopharma Plastic Market in the forecast period.

Polyvinyl chloride (PVC) will be the Key Polymer Type.

The versatility of polyvinyl chloride in the market is due to its capacity to withstand a variety of operations without breaking or cracking. It is ideal for creating syringes, disposable connections, depth filters, and other biopharma plastic products since it is flexible, UV and chemical resistant, and can readily manage high temperatures. Along with having outstanding mechanical properties, they have oxidation resistance capacity, water repellency with simultaneous vapor permeability, and water repellency. As a result, the product is long-lasting, sustainable, and cost-effective, which has increased the use of biopharma plastics in protective wear in the healthcare sector.

For instance, in 2021, according to MPN, PVC was the most used polymer for single-use medical devices such as bags, tubing, masks, and other disposal devices.

In addition, polytetrafluoroethylene and polyethylene are used in various applications due to their properties, such as durability, gloss, and detergent resistance.

Therefore, the aforementioned factors are likely to boost market growth over the forecast period.

Recent Developments

  • In November 2022, Avantor Inc. opened New Distribution Center in Dublin, Ireland, to support the Biopharma market.
  • Solvay signed MOUs with French start-up Ostiumin to enable the mechanical recycling of end-of-life single-use surgical instruments molded in glass-fiber reinforced in November 2022.
  • In September 2022, Hanwha Solutions Corporation started using the LyondellBasell Lupotech T high-pressure polyethylene technology in Yeosu, South Korea.
  • DuPont Liveo, a healthcare solutions manufacturing facility started at the Cooper River Site in South Carolina, opened by DuPont in July 2022.

Market Segmentation

Global Biopharma Plastics Market is segmented based on polymer type, application, and region. Based on the polymer type, the market is fragmented into polyvinyl chloride (PVC), polyethylene terephthalate (PET), polypropylene (PP), and others. Based on the application, the market is segmented into protective wear, containers, bioreactor bags, syringes, and others. Based on region, the market is divided into North America, Europe, Asia Pacific, South America, Middle East & Africa, By Company.

Market Players

BASF SE, Spectrum Plastics Group, Celanese Corporation, LyondellBasell Industries Holdings B.V., DuPont de Nemours, Inc., Tekni-Plex, Inc., Solvay S.A., Avantor, Inc., Bormioli Pharma S.p.A., Saudi Basic Industries Corporation are some of the key players of Global Biopharma Plastics Market.

Report Scope

In this report, Global Biopharma Plastics market has been segmented into the following categories, in addition to the industry trends, which have also been detailed below:

Biopharma Plastics Market, By Polymer Type:

  • Polyvinyl Chloride (PVC)
  • Polyethylene Terephthalate (PET)
  • Polypropylene (PP)
  • Others

Biopharma Plastics Market, By Application:

  • Protective Wear
  • Containers
  • Bioreactor Bags
  • Syringes
  • Others

Biopharma Plastics Market, By Region:

  • North America
    • United States
    • Mexico
    • Canada
  • Europe
    • France
    • Germany
    • United Kingdom
    • Spain
    • Italy
  • Asia-Pacific
    • China
    • India
    • South Korea
    • Japan
    • Indonesia
  • South America
    • Brazil
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive landscape

Company Profiles: Detailed analysis of the major companies present in Global Biopharma Plastics market.

Available Customizations

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Biopharma Plastics Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value & Volume
  • 5.2. Market Share & Forecast
    • 5.2.1. By Polymer Type (Polyvinyl Chloride (PVC), Polyethylene Terephthalate (PET), Polypropylene (PP), Others)
    • 5.2.2. By Application (Protective Wear, Containers, Bioreactor Bags, Syringes, Others)
    • 5.2.3. By Region (North America, Europe, Asia Pacific, South America, Middle East & Africa)
    • 5.2.4. By Company (2022)
  • 5.3. Market Map
    • 5.3.1. By Polymer Type
    • 5.3.2. By Application
    • 5.3.3. By Region

6. North America Biopharma Plastics Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value & Volume
  • 6.2. Market Share & Forecast
    • 6.2.1. By Polymer Type
    • 6.2.2. By Application
    • 6.2.3. By Country
  • 6.3. Pricing Analysis
  • 6.4. North America: Country Analysis
    • 6.4.1. United States Biopharma Plastics Market Outlook
      • 6.4.1.1. Market Size & Forecast
        • 6.4.1.1.1. By Value & Volume
      • 6.4.1.2. Market Share & Forecast
        • 6.4.1.2.1. By Polymer Type
        • 6.4.1.2.2. By Application
    • 6.4.2. Mexico Biopharma Plastics Market Outlook
      • 6.4.2.1. Market Size & Forecast
        • 6.4.2.1.1. By Value & Volume
      • 6.4.2.2. Market Share & Forecast
        • 6.4.2.2.1. By Polymer Type
        • 6.4.2.2.2. By Application
    • 6.4.3. Canada Biopharma Plastics Market Outlook
      • 6.4.3.1. Market Size & Forecast
        • 6.4.3.1.1. By Value & Volume
      • 6.4.3.2. Market Share & Forecast
        • 6.4.3.2.1. By Polymer Type
        • 6.4.3.2.2. By Application

7. Europe Biopharma Plastics Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value & Volume
  • 7.2. Market Share & Forecast
    • 7.2.1. By Polymer Type
    • 7.2.2. By Application
    • 7.2.3. By Country
  • 7.3. Pricing Analysis
  • 7.4. Europe: Country Analysis
    • 7.4.1. France Biopharma Plastics Market Outlook
      • 7.4.1.1. Market Size & Forecast
        • 7.4.1.1.1. By Value & Volume
      • 7.4.1.2. Market Share & Forecast
        • 7.4.1.2.1. By Polymer Type
        • 7.4.1.2.2. By Application
    • 7.4.2. Germany Biopharma Plastics Market Outlook
      • 7.4.2.1. Market Size & Forecast
        • 7.4.2.1.1. By Value & Volume
      • 7.4.2.2. Market Share & Forecast
        • 7.4.2.2.1. By Polymer Type
        • 7.4.2.2.2. By Application
    • 7.4.3. United Kingdom Biopharma Plastics Market Outlook
      • 7.4.3.1. Market Size & Forecast
        • 7.4.3.1.1. By Value & Volume
      • 7.4.3.2. Market Share & Forecast
        • 7.4.3.2.1. By Polymer Type
        • 7.4.3.2.2. By Application
    • 7.4.4. Spain Biopharma Plastics Market Outlook
      • 7.4.4.1. Market Size & Forecast
        • 7.4.4.1.1. By Value & Volume
      • 7.4.4.2. Market Share & Forecast
        • 7.4.4.2.1. By Polymer Type
        • 7.4.4.2.2. By Application
    • 7.4.5. Italy Biopharma Plastics Market Outlook
      • 7.4.5.1. Market Size & Forecast
        • 7.4.5.1.1. By Value & Volume
      • 7.4.5.2. Market Share & Forecast
        • 7.4.5.2.1. By Polymer Type
        • 7.4.5.2.2. By Application

8. Asia-Pacific Biopharma Plastics Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value & Volume
  • 8.2. Market Share & Forecast
    • 8.2.1. By Polymer Type
    • 8.2.2. By Application
    • 8.2.3. By Country
  • 8.3. Pricing Analysis
  • 8.4. Asia-Pacific: Country Analysis
    • 8.4.1. China Biopharma Plastics Market Outlook
      • 8.4.1.1. Market Size & Forecast
        • 8.4.1.1.1. By Value & Volume
      • 8.4.1.2. Market Share & Forecast
        • 8.4.1.2.1. By Polymer Type
        • 8.4.1.2.2. By Application
    • 8.4.2. India Biopharma Plastics Market Outlook
      • 8.4.2.1. Market Size & Forecast
        • 8.4.2.1.1. By Value & Volume
      • 8.4.2.2. Market Share & Forecast
        • 8.4.2.2.1. By Polymer Type
        • 8.4.2.2.2. By Application
    • 8.4.3. South Korea Biopharma Plastics Market Outlook
      • 8.4.3.1. Market Size & Forecast
        • 8.4.3.1.1. By Value & Volume
      • 8.4.3.2. Market Share & Forecast
        • 8.4.3.2.1. By Polymer Type
        • 8.4.3.2.2. By Application
    • 8.4.4. Japan Biopharma Plastics Market Outlook
      • 8.4.4.1. Market Size & Forecast
        • 8.4.4.1.1. By Value & Volume
      • 8.4.4.2. Market Share & Forecast
        • 8.4.4.2.1. By Polymer Type
        • 8.4.4.2.2. By Application
    • 8.4.5. Indonesia Biopharma Plastics Market Outlook
      • 8.4.5.1. Market Size & Forecast
        • 8.4.5.1.1. By Value & Volume
      • 8.4.5.2. Market Share & Forecast
        • 8.4.5.2.1. By Polymer Type
        • 8.4.5.2.2. By Application

9. South America Biopharma Plastics Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value & Volume
  • 9.2. Market Share & Forecast
    • 9.2.1. By Polymer Type
    • 9.2.2. By Application
    • 9.2.3. By Country
  • 9.3. Pricing Analysis
  • 9.4. South America: Country Analysis
    • 9.4.1. Brazil Biopharma Plastics Market Outlook
      • 9.4.1.1. Market Size & Forecast
        • 9.4.1.1.1. By Value & Volume
      • 9.4.1.2. Market Share & Forecast
        • 9.4.1.2.1. By Polymer Type
        • 9.4.1.2.2. By Application
    • 9.4.2. Argentina Biopharma Plastics Market Outlook
      • 9.4.2.1. Market Size & Forecast
        • 9.4.2.1.1. By Value & Volume
      • 9.4.2.2. Market Share & Forecast
        • 9.4.2.2.1. By Polymer Type
        • 9.4.2.2.2. By Application

10. Middle East and Africa Biopharma Plastics Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value & Volume
  • 10.2. Market Share & Forecast
    • 10.2.1. By Polymer Type
    • 10.2.2. By Application
    • 10.2.3. By Country
  • 10.3. Pricing Analysis
  • 10.4. MEA: Country Analysis
    • 10.4.1. South Africa Biopharma Plastics Market Outlook
      • 10.4.1.1. Market Size & Forecast
        • 10.4.1.1.1. By Value & Volume
      • 10.4.1.2. Market Share & Forecast
        • 10.4.1.2.1. By Polymer Type
        • 10.4.1.2.2. By Application
    • 10.4.2. Saudi Arabia Biopharma Plastics Market Outlook
      • 10.4.2.1. Market Size & Forecast
        • 10.4.2.1.1. By Value & Volume
      • 10.4.2.2. Market Share & Forecast
        • 10.4.2.2.1. By Polymer Type
        • 10.4.2.2.2. By Application
    • 10.4.3. UAE Biopharma Plastics Market Outlook
      • 10.4.3.1. Market Size & Forecast
        • 10.4.3.1.1. By Value & Volume
      • 10.4.3.2. Market Share & Forecast
        • 10.4.3.2.1. By Polymer Type
        • 10.4.3.2.2. By Application

11. Market Dynamics

  • 11.1. Drivers
    • 11.1.1. Increase in healthcare expenditure
    • 11.1.2. Rising cases of cancerous patients
    • 11.1.3. Technological advancement in healthcare
  • 11.2. Challenges
    • 11.2.1. Fluctuation in Raw Material prices
    • 11.2.2. Stringent Government regulations

12. Market Trends & Developments

  • 12.1. Product Launches
  • 12.2. Mergers & Acquisitions
  • 12.3. Technological Advancements

13. Global Biopharma Plastics Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Types

15. Competitive Landscape

  • 15.1. Business Overview
  • 15.2. Type Offerings
  • 15.3. Recent Developments
  • 15.4. Financials (In Case of Listed Companies)
  • 15.5. Key Personnel
  • 15.6. SWOT Analysis
    • 15.6.1. BASF SE
    • 15.6.2. Spectrum Plastics Group
    • 15.6.3. Celanese Corporation
    • 15.6.4. LyondellBasell Industries Holdings B.V.
    • 15.6.5. DuPont de Nemours, Inc.
    • 15.6.6. Tekni-Plex, Inc.
    • 15.6.7. Solvay S.A.
    • 15.6.8. Avantor, Inc.
    • 15.6.9. Bormioli Pharma S.p.A.
    • 15.6.10. Saudi Basic Industries Corporation

16. Strategic Recommendations